Experimental Drug Halts Parkinson’s Progression in Mice
Summary: An experimental drug related to diabetes medications slows Parkinson’s disease progression and reduces symptoms in mouse models, according to Johns Hopkins researchers. Source: Johns Hopkins Medicine. Johns Hopkins researchers report that an experimental compound, NLY01, which targets glucagon-like peptide-1 receptors similar to some diabetes drugs, slows the underlying progression of Parkinson’s disease and preserves … Read more